ROS and the DNA damage response in cancer

by Srinivas, U.S., Tan, B.W.Q., Vellayappan, B.A., Jeyasekharan, A.D.
Published 2021

A-Type Lamins Maintain the Positional Stability of DNA Damage Repair Foci in Mammalian Nuclei

by Mahen R., Hattori H., Lee M., Sharma P., Jeyasekharan A.D., Venkitaraman A.R.
Published 2019

The genomics and molecular biology of natural killer/T-cell lymphoma: Opportunities for translation

by de Mel S., Soon G.S.-T., Mok Y., Chung T.-H., Jeyasekharan A.D., Chng W.-J., Ng S.-B.
Published 2019

NF-κB signaling mediates acquired resistance after PARP inhibition

by Nakagawa, Y, Sedukhina, A.S, Okamoto, N, Nagasawa, S, Suzuki, N, Ohta, T, Hattori, H, Roche-Molina, M, Narváez, A.J, Jeyasekharan, A.D, Bernal, J.A, Sato, K
Published 2020

OTUD4 enhances TGF? signalling through regulation of the TGF? receptor complex

by Jaynes, P.W., Iyengar, P.V., Lui, S.K.L., Tan, T.Z., Vasilevski, N., Wright, S.C.E., Verdile, G., Jeyasekharan, A.D., Eichhorn, P.J.A.
Published 2021

Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot study

by Sundar, R, Bandla, A, Tan, S.S.H, Liao, L.-D, Kumarakulasinghe, N.B, Jeyasekharan, A.D, Ow, S.G.W, Ho, J, Tan, D.S.P, Lim, J.S.J, Vijayan, J, Therimadasamy, A.K, Hairom, Z, Ang, E, Ang, S, Thakor, N.V, Lee, S.-C, Wilder-Smith, E.P.V
Published 2020

CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer

by Roy R.K., Hoppe M.M., Srivastava S., Samanta A., Sharma N., Tan K.T., Yang H., Voon D.C., Pang B., Teh M., Murata-Kamiya N., Hatakeyama M., Chang Y.-T., Yong W.P., Ito Y., Ho K.Y., Tan P., Soong R., Koeffler P.H., Yeoh K.G., Jeyasekharan A.D.
Published 2020

Low Levels of NDRG1 in nerve tissue are predictive of severe paclitaxel-induced neuropathy

by Sundar R., Jeyasekharan A.D., Pang B., Soong R.C.T., Kumarakulasinghe N.B., Ow S.G.W., Ho J., Lim J.S.J., Tan D.S.P., Wilder-Smith E.P.V., Bandla A., Tan S.S.H., Asuncion B.R., Fazreen Z., Hoppe M.M., Putti T.C., Poh L.M., Goh B.C., Lee S.-C.
Published 2018

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

by Wong A.L.A., Sundar R., Wang T.-T., Ng T.-C., Zhang B., Tan S.-H., Soh T.I.P., Pang A.S.L., Tan C.-S., Ow S.G.W., Wang L., Mogro J., Ho J., Jeyasekharan A.D., Huang Y., Thng C.-H., Chan C.-W., Hartman M., Iau P., Buhari S.A., Goh B.-C., Lee S.-C.
Published 2020

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma

by de Mel, S., Rashid, M.B.M., Zhang, X.Y., Goh, J., Lee, C.T., Poon, L.M., Chan, E.H.L., Liu, X., Chng, W.J., Chee, Y.L., Lee, J., Yuen, Y.C., Lim, J.Q., Chia, B.K.H., Laurensia, Y., Huang, D.C., Pang, W.L., Cheah, D.M.Z., Wong, E.K.Y., Ong, C.K., Tang, T., Lim, S.T., Ng, S.B., Tan, S.Y., Loi, H.-Y., Tan, L.K., Chow, E.K., Jeyasekharan, A.D.
Published 2021